sotalol has been researched along with BOOP in 1 studies
Sotalol: An adrenergic beta-antagonist that is used in the treatment of life-threatening arrhythmias.
sotalol : A sulfonamide that is N-phenylmethanesulfonamide in which the phenyl group is substituted at position 4 by a 1-hydroxy-2-(isopropylamino)ethyl group. It has both beta-adrenoreceptor blocking (Vaughan Williams Class II) and cardiac action potential duration prolongation (Vaughan Williams Class III) antiarrhythmic properties. It is used (usually as the hydrochloride salt) for the management of ventricular and supraventricular arrhythmias.
Excerpt | Relevance | Reference |
---|---|---|
" Tapering off corticosteroid dosage resulted in relapse, and complete recovery was only obtained after sotalol was stopped." | 1.30 | Migratory pulmonary infiltrates in a patient treated with sotalol. ( Faller, M; Gangi, A; Gasser, B; Mathelin, C; Pauli, G; Popin, E; Quoix, E, 1997) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Faller, M | 1 |
Quoix, E | 1 |
Popin, E | 1 |
Gangi, A | 1 |
Gasser, B | 1 |
Mathelin, C | 1 |
Pauli, G | 1 |
1 other study available for sotalol and BOOP
Article | Year |
---|---|
Migratory pulmonary infiltrates in a patient treated with sotalol.
Topics: Adrenergic beta-Antagonists; Cryptogenic Organizing Pneumonia; Female; Humans; Lung; Lung Diseases; | 1997 |